Payer and Pharma Sidekick's established collaborations with the largest U.S. health insurer and with pharma leaders such as Eli Lilly and Pfizer create ready-made entry points to expand digital therapeutics across payer and pharma channels. Opportunity: pursue multi-program contracts, bundled care pathways, and co-developed solutions addressing multi-morbidity.

Integrated MSK & Obesity Recent launches of a musculoskeletal health program and obesity management solutions, including integration with Ypsomed autoinjectors, signal growing demand for device-enabled digital therapeutics. Opportunity: partner with hospitals, health systems, and employer groups to deploy integrated MSK and obesity care bundles.

Adaptive CarePaths Adaptive CarePaths consolidate multiple programs into a single platform, offering a streamlined solution for health systems managing patients with multiple chronic conditions. Opportunity: position as a scalable enterprise solution with strong care management ROI, enabling joint sales with insurers and pharma.

US Market Access With U.S. market engagement across Medicare, Medicaid, and Commercial segments and offices in Reykjavik and Hamburg, Sidekick has a scalable footprint for enterprise deployments in larger health plans and regional systems. Opportunity: target large employers, MSK and obesity initiatives, and chronic disease programs through plan-level partnerships.

Tech-Driven Readiness A mature tech stack with workflow orchestration (Apache Airflow), CRM/marketing tools (HubSpot), and integration-ready platforms supports IT and clinical stakeholder demonstrations and potential EHR integrations. Opportunity: leverage data capabilities to deliver value demos, privacy-compliant analytics, and provider-facing dashboards to win IT and clinician stakeholders.